Dermatology NewsAFib, CVD risks similar after ustekinumab and TNF inhibitors in psoriatic patientsApril 9, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsProinflammatory diet may not trigger adult psoriasis, PsA, or ADMarch 30, 2019PsoriasisPsoriatic ArthritisAtopic Dermatitis
Dermatology NewsTNF inhibitor–induced psoriasis in IBD patients a considerationMarch 26, 2019PsoriasisNonmelanoma Skin CancerMelanoma
Dermatology NewsHerpes zoster risk increased with some psoriasis, psoriatic arthritis treatmentsMarch 22, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsImmunomodulators for pediatric skin diseasesMarch 14, 2019PediatricsMedical DermatologyAtopic DermatitisPsoriasis
Dermatology NewsFDA approves patient-controlled injector for guselkumabMarch 8, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsIxekizumab psoriasis outcomes, sliced and dicedFebruary 23, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsAAD, NPF release two joint guidelines on treatment, management of psoriasisFebruary 21, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsTNF inhibitor prices rose despite increased drug class competitionFebruary 20, 2019Business of MedicinePsoriasisPractice Management
Dermatology NewsBiologics curb coronary artery plaques in severe psoriasisFebruary 10, 2019PsoriasisPsoriatic Arthritis
Dermatology NewsDifferent disease features found with family history of psoriasis versus PsAFebruary 7, 2019Psoriatic ArthritisPsoriasis
Safety and Efficacy of Halobetasol Propionate Lotion 0.01% in the Treatment of Moderate to Severe Plaque Psoriasis: A Pooled Analysis of 2 Phase 3 StudiesFebruary 5, 2019Psoriasis
